-
1
-
-
79951809968
-
Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing
-
Epub 2011 Jan 26
-
Relling MV, Gardner EE, Sandborn WJ, et al. Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther 2011;89(3):387-91 Epub 2011 Jan 26.
-
(2011)
Clin Pharmacol Ther
, vol.89
, Issue.3
, pp. 387-391
-
-
Relling, M.V.1
Gardner, E.E.2
Sandborn, W.J.3
-
3
-
-
0036721011
-
Determination of thiopurine methyltransferase genotype or phenotype optimizes initial dosing of azathioprine for the treatment of Crohn's disease
-
Regueiro M, Mardini H. Determination of thiopurine methyltransferase genotype or phenotype optimizes initial dosing of azathioprine for the treatment of Crohn's disease. J Clin Gastroenterol 2002:35(3):240-244.
-
(2002)
J Clin Gastroenterol
, vol.35
, Issue.3
, pp. 240-244
-
-
Regueiro, M.1
Mardini, H.2
-
4
-
-
84867468722
-
-
Quest Diagnostics, Available at, Accessed on 23 Sept
-
Quest Diagnostics. TPMT genotype. Available at: http://www.questdiagnostics.com/hcp/intguide/jsp/showintguidepage.jsp?fn=Immuno/TS_TPMT_Genotype.htm. Accessed on 23 Sept 2010.
-
(2010)
TPMT Genotype
-
-
-
5
-
-
84867468721
-
-
Sonora Quest Laboratories, Available at, Accessed 24 Feb
-
Sonora Quest Laboratories. TPMT genotype. Available at: http://www.sonoraquest.com/test-information/tpmt-genotype/. Accessed 24 Feb 2011.
-
(2011)
TPMT Genotype
-
-
-
6
-
-
63849218270
-
Normal thiopurine methyltransferase phenotype in a Crohn disease patient with azathioprine induced myelosuppression
-
Leung M, Piatkov I, Rochester C, et al. Normal thiopurine methyltransferase phenotype in a Crohn disease patient with azathioprine induced myelosuppression. Intern Med J 2009;39:121-126.
-
(2009)
Intern Med J
, vol.39
, pp. 121-126
-
-
Leung, M.1
Piatkov, I.2
Rochester, C.3
-
7
-
-
67650089568
-
Severe myelosuppression following alopecia shortly after the initiation of 6-mercaptopurine in a patient with Crohn's disease
-
Ugajin T, Miyatani H, Demitsu T, et al. Severe myelosuppression following alopecia shortly after the initiation of 6-mercaptopurine in a patient with Crohn's disease. Intern Med 2009;48(9):693-695.
-
(2009)
Intern Med
, vol.48
, Issue.9
, pp. 693-695
-
-
Ugajin, T.1
Miyatani, H.2
Demitsu, T.3
-
8
-
-
0034812896
-
Is neutropenia required for effective maintenance of remission during azathioprine therapy in inflammatory bowel disease?
-
Campbell S, Gosh S. Is neutropenia required for effective maintenance of remission during azathioprine therapy in inflammatory bowel disease? Eur J Gastroenterol Hepatol 2001;13(9):1073-1076.
-
(2001)
Eur J Gastroenterol Hepatol
, vol.13
, Issue.9
, pp. 1073-1076
-
-
Campbell, S.1
Gosh, S.2
-
9
-
-
0028855269
-
Fatal infectious mononucleosis: A severe complication in the treatment of Crohn's disease with azathioprine
-
Posthuma EE, Westendorp RG, van der Sluvs VA, et al. Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine. Gut 1995;36(2):311-313.
-
(1995)
Gut
, vol.36
, Issue.2
, pp. 311-313
-
-
Posthuma, E.E.1
Westendorp, R.G.2
van der Sluvs, V.A.3
-
10
-
-
0027164795
-
Bone marrow toxicity caused by azathioprine inflammatory bowel disease: 27 years of experience
-
Connell WR, Kamm MA, Ritchie JK, et al. Bone marrow toxicity caused by azathioprine inflammatory bowel disease: 27 years of experience. Gut 1993;34:1081-1085.
-
(1993)
Gut
, vol.34
, pp. 1081-1085
-
-
Connell, W.R.1
Kamm, M.A.2
Ritchie, J.K.3
-
11
-
-
0027401302
-
Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient
-
Schütz E, Gummert J, Mohr F, et al. Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient. Lancet 1993;341:436.
-
(1993)
Lancet
, vol.341
, pp. 436
-
-
Schütz, E.1
Gummert, J.2
Mohr, F.3
-
12
-
-
67749132476
-
Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain
-
Gurwitz D, Rodríguez-Antona C, Payne K, et al. Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain. Eur J Hum Genet 2009;17(8):991-998.
-
(2009)
Eur J Hum Genet
, vol.17
, Issue.8
, pp. 991-998
-
-
Gurwitz, D.1
Rodríguez-Antona, C.2
Payne, K.3
-
13
-
-
4344602852
-
Guidelines for the management of inflammatory bowel disease in adults
-
Carter MJ, Lobo AJ, Travis SP, et al. Guidelines for the management of inflammatory bowel disease in adults. Guts 2004;53(Suppl 5):v1-16.
-
(2004)
Guts
, vol.53
, Issue.5 SUPPL.
-
-
Carter, M.J.1
Lobo, A.J.2
Travis, S.P.3
-
14
-
-
0024457688
-
6-mercaptopurine in the management of inflammatory bowel disease: Short-and long-term toxicity
-
Present DH, Meltzer SJ, Krumholz MP, et al. 6-mercaptopurine in the management of inflammatory bowel disease: short-and long-term toxicity. Ann Intern Med 1989;111(8):641-649.
-
(1989)
Ann Intern Med
, vol.111
, Issue.8
, pp. 641-649
-
-
Present, D.H.1
Meltzer, S.J.2
Krumholz, M.P.3
-
15
-
-
71749114818
-
Timing of myelosuppression during thiopurine therapy for inflammatory bowel disease: Implications for monitoring recommendations
-
Lewis JD, Abramson O, Pascua M, Liu L, Asakura LM, Velayos FS, et al. Timing of myelosuppression during thiopurine therapy for inflammatory bowel disease: implications for monitoring recommendations. Clin Gastroenterol Hepatol 2009:7(11);1195-1201.
-
(2009)
Clin Gastroenterol Hepatol
, vol.7
, Issue.11
, pp. 1195-1201
-
-
Lewis, J.D.1
Abramson, O.2
Pascua, M.3
Liu, L.4
Asakura, L.M.5
Velayos, F.S.6
-
16
-
-
77949269528
-
Erratum: Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Paremeters Committee
-
The Practice Parameters Committee of the American College of Gastroenterology
-
Korbluth A, Sachar DB and The Practice Parameters Committee of the American College of Gastroenterology. Erratum: ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Paremeters Committee. Ams J Gastroenterol 2010;105:500-523.
-
(2010)
Ams J Gastroenterol
, vol.105
, pp. 500-523
-
-
Korbluth, A.1
Sachar, D.B.2
-
17
-
-
84867445587
-
-
Tabloid [package insert], Research Triangle Park, NC: GlaxoSmithKline
-
Tabloid [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2004.
-
(2004)
-
-
-
18
-
-
79955463893
-
Pharmacogenetics: From bench to byte-an update of guidelines
-
Swen JJ, Nijenhuis M, de Boer A, et al. Pharmacogenetics: from bench to byte-an update of guidelines. Clin Pharm Ther 2011;89(5):662-673.
-
(2011)
Clin Pharm Ther
, vol.89
, Issue.5
, pp. 662-673
-
-
Swen, J.J.1
Nijenhuis, M.2
de Boer, A.3
-
19
-
-
77950387206
-
Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment: A pharmacogenomic test whose time has come
-
Ford LT, Berg JD. Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment: a pharmacogenomic test whose time has come. J Clin Pathol 2010;63:288-295.
-
(2010)
J Clin Pathol
, vol.63
, pp. 288-295
-
-
Ford, L.T.1
Berg, J.D.2
-
20
-
-
84867445588
-
-
Imuran [package insert]. San Diego, CA: Prometheus Laboratories, Inc
-
Imuran [package insert]. San Diego, CA: Prometheus Laboratories, Inc.; 2009.
-
(2009)
-
-
-
21
-
-
84867468723
-
-
Purinethol [package insert]. Greenville, NC: DSM Pharmaceuticals, Inc
-
Purinethol [package insert]. Greenville, NC: DSM Pharmaceuticals, Inc.; 2003.
-
(2003)
-
-
-
22
-
-
84867481326
-
-
US Food and Drug Administration, Available at, Accessed 24 Feb
-
US Food and Drug Administration. Table of pharmacogenomics markers. Available at: http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm083378.htm. Accessed 24 Feb 2011.
-
(2011)
Table of Pharmacogenomics Markers
-
-
-
23
-
-
79953201846
-
Systematic review of thiopurine methyltransferase genotype and enzymatic testing strategies
-
Donnan JR, Ungar WJ, Matthews M, et al. Systematic review of thiopurine methyltransferase genotype and enzymatic testing strategies. Ther Drug Monit 2011;33(2):192-199.
-
(2011)
Ther Drug Monit
, vol.33
, Issue.2
, pp. 192-199
-
-
Donnan, J.R.1
Ungar, W.J.2
Matthews, M.3
-
24
-
-
23044499897
-
Thiopurines in inflammatory bowel disease: Pharmacogenetics, therapeutics, drug monitoring and clinical recommendations
-
Al Hadithy AF, de Boer NK, Derijks L J, et al. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutics, drug monitoring and clinical recommendations. Dig Liv Dis 2005;37:282+297.
-
(2005)
Dig Liv Dis
, vol.37
, Issue.282
, pp. 297
-
-
Al, H.A.F.1
de Boer, N.K.2
Derijks, L.J.3
-
25
-
-
27644565720
-
Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: Early experience of use in clinical practice
-
Gearry RB, Barclay ML, Roberts RL, et al. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice. Intern Med J 2005;35(10):580-585.
-
(2005)
Intern Med J
, vol.35
, Issue.10
, pp. 580-585
-
-
Gearry, R.B.1
Barclay, M.L.2
Roberts, R.L.3
-
27
-
-
0033830262
-
Allelic variants of the thiopurine S-methyltransferase deficiency in patients with ulcerative colitis and in healthy control
-
Corominas H, Domènech M, González D, et al. Allelic variants of the thiopurine S-methyltransferase deficiency in patients with ulcerative colitis and in healthy control. Am J Gastroenterol 2000;95(9):2131-2317.
-
(2000)
Am J Gastroenterol
, vol.95
, Issue.9
, pp. 2131-2317
-
-
Corominas, H.1
Domènech, M.2
González, D.3
-
28
-
-
68749111832
-
Adverse reactions to azathioprine cannot be predicted by thiopurine s-methyltransferase genotype in Japanese patients with inflammatory bowel disease
-
Takatsu N, Matsui T, Murakami Y, et al. Adverse reactions to azathioprine cannot be predicted by thiopurine s-methyltransferase genotype in Japanese patients with inflammatory bowel disease. J Gastroenterol Hepatol 2009;24(7):1258-1264.
-
(2009)
J Gastroenterol Hepatol
, vol.24
, Issue.7
, pp. 1258-1264
-
-
Takatsu, N.1
Matsui, T.2
Murakami, Y.3
-
29
-
-
0036260109
-
Molecular analysis of thiopurine S-methyltransferase alleles in South-east Asian populations
-
Chang J, Lee L, Chen C, et al. Molecular analysis of thiopurine S-methyltransferase alleles in South-east Asian populations. Pharmacogenetics 2002;12:191-195.
-
(2002)
Pharmacogenetics
, vol.12
, pp. 191-195
-
-
Chang, J.1
Lee, L.2
Chen, C.3
-
30
-
-
0036668038
-
Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: Impact of thiopurine S-methyltransferase polymorphism
-
Schwab M, Schäffeler E, Marx C, et al. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism. Pharmacogenetics 2002;12(6):429-436.
-
(2002)
Pharmacogenetics
, vol.12
, Issue.6
, pp. 429-436
-
-
Schwab, M.1
Schäffeler, E.2
Marx, C.3
-
31
-
-
52149099443
-
Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease
-
Ansari A, Arenas M, Greenfield SM, et al. Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease. Aliment Pharmacol Ther 2008;28(8):973-983.
-
(2008)
Aliment Pharmacol Ther
, vol.28
, Issue.8
, pp. 973-983
-
-
Ansari, A.1
Arenas, M.2
Greenfield, S.M.3
-
32
-
-
0034093057
-
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
-
Colombel JF, Ferrari N, Debuysere H, et al. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology 2000;118(6):1025-1030.
-
(2000)
Gastroenterology
, vol.118
, Issue.6
, pp. 1025-1030
-
-
Colombel, J.F.1
Ferrari, N.2
Debuysere, H.3
-
33
-
-
68649101215
-
Impact of heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand
-
Vannaprasaht S, Angsuthum S, Avihingsanon Y, et al. Impact of heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand. Clin Ther 2009;31(7):1524-1533.
-
(2009)
Clin Ther
, vol.31
, Issue.7
, pp. 1524-1533
-
-
Vannaprasaht, S.1
Angsuthum, S.2
Avihingsanon, Y.3
-
34
-
-
34247159530
-
Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease
-
Winter JW, Gaffney D, Shapiro D, et al. Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2007;25(9):1069-1077.
-
(2007)
Aliment Pharmacol Ther
, vol.25
, Issue.9
, pp. 1069-1077
-
-
Winter, J.W.1
Gaffney, D.2
Shapiro, D.3
-
35
-
-
23244464086
-
The impact of thiopurine S-methyltrasferase polymorphism on azathioprine-induced myelotoxicity in renal transplant patients
-
Kurzawski M, Dziewanowski K, Gawrońska-Szklarz B, et al. The impact of thiopurine S-methyltrasferase polymorphism on azathioprine-induced myelotoxicity in renal transplant patients. Ther Drug Monit 2005;27(4):435-441.
-
(2005)
Ther Drug Monit
, vol.27
, Issue.4
, pp. 435-441
-
-
Kurzawski, M.1
Dziewanowski, K.2
Gawrońska-Szklarz, B.3
-
36
-
-
77349123020
-
Importance of thiopurine S-methyltransferase gene polymorphisms for prediction of azathioprine toxicity
-
Kolorz M, Bartosova L, Hosek J, et al. Importance of thiopurine S-methyltransferase gene polymorphisms for prediction of azathioprine toxicity. Neuro Endocrinol Lett 2009;30(Suppl 1):137-142.
-
(2009)
Neuro Endocrinol Lett
, vol.30
, Issue.1 SUPPL.
, pp. 137-142
-
-
Kolorz, M.1
Bartosova, L.2
Hosek, J.3
-
37
-
-
27744574836
-
A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine
-
Dubinsky MC, Reyes E, Ofman J, et al. A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Am J Gastroenterol 2005;100(10):2239-2247.
-
(2005)
Am J Gastroenterol
, vol.100
, Issue.10
, pp. 2239-2247
-
-
Dubinsky, M.C.1
Reyes, E.2
Ofman, J.3
|